Cargando…
Association of a novel point mutation in MSH2 gene with familial multiple primary cancers
BACKGROUND: Multiple primary cancers (MPC) have been identified as two or more cancers without any subordinate relationship that occur either simultaneously or metachronously in the same or different organs of an individual. Lynch syndrome is an autosomal dominant genetic disorder that increases the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627420/ https://www.ncbi.nlm.nih.gov/pubmed/28974240 http://dx.doi.org/10.1186/s13045-017-0523-y |
_version_ | 1783268712193720320 |
---|---|
author | Hu, Hai Li, Hong Jiao, Feng Han, Ting Zhuo, Meng Cui, Jiujie Li, Yixue Wang, Liwei |
author_facet | Hu, Hai Li, Hong Jiao, Feng Han, Ting Zhuo, Meng Cui, Jiujie Li, Yixue Wang, Liwei |
author_sort | Hu, Hai |
collection | PubMed |
description | BACKGROUND: Multiple primary cancers (MPC) have been identified as two or more cancers without any subordinate relationship that occur either simultaneously or metachronously in the same or different organs of an individual. Lynch syndrome is an autosomal dominant genetic disorder that increases the risk of many types of cancers. Lynch syndrome patients who suffer more than two cancers can also be considered as MPC; patients of this kind provide unique resources to learn how genetic mutation causes MPC in different tissues. METHODS: We performed a whole genome sequencing on blood cells and two tumor samples of a Lynch syndrome patient who was diagnosed with five primary cancers. The mutational landscape of the tumors, including somatic point mutations and copy number alternations, was characterized. We also compared Lynch syndrome with sporadic cancers and proposed a model to illustrate the mutational process by which Lynch syndrome progresses to MPC. RESULTS: We revealed a novel pathologic mutation on the MSH2 gene (G504 splicing) that associates with Lynch syndrome. Systematical comparison of the mutation landscape revealed that multiple cancers in the proband were evolutionarily independent. Integrative analysis showed that truncating mutations of DNA mismatch repair (MMR) genes were significantly enriched in the patient. A mutation progress model that included germline mutations of MMR genes, double hits of MMR system, mutations in tissue-specific driver genes, and rapid accumulation of additional passenger mutations was proposed to illustrate how MPC occurs in Lynch syndrome patients. CONCLUSION: Our findings demonstrate that both germline and somatic alterations are driving forces of carcinogenesis, which may resolve the carcinogenic theory of Lynch syndrome. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13045-017-0523-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5627420 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56274202017-10-12 Association of a novel point mutation in MSH2 gene with familial multiple primary cancers Hu, Hai Li, Hong Jiao, Feng Han, Ting Zhuo, Meng Cui, Jiujie Li, Yixue Wang, Liwei J Hematol Oncol Research BACKGROUND: Multiple primary cancers (MPC) have been identified as two or more cancers without any subordinate relationship that occur either simultaneously or metachronously in the same or different organs of an individual. Lynch syndrome is an autosomal dominant genetic disorder that increases the risk of many types of cancers. Lynch syndrome patients who suffer more than two cancers can also be considered as MPC; patients of this kind provide unique resources to learn how genetic mutation causes MPC in different tissues. METHODS: We performed a whole genome sequencing on blood cells and two tumor samples of a Lynch syndrome patient who was diagnosed with five primary cancers. The mutational landscape of the tumors, including somatic point mutations and copy number alternations, was characterized. We also compared Lynch syndrome with sporadic cancers and proposed a model to illustrate the mutational process by which Lynch syndrome progresses to MPC. RESULTS: We revealed a novel pathologic mutation on the MSH2 gene (G504 splicing) that associates with Lynch syndrome. Systematical comparison of the mutation landscape revealed that multiple cancers in the proband were evolutionarily independent. Integrative analysis showed that truncating mutations of DNA mismatch repair (MMR) genes were significantly enriched in the patient. A mutation progress model that included germline mutations of MMR genes, double hits of MMR system, mutations in tissue-specific driver genes, and rapid accumulation of additional passenger mutations was proposed to illustrate how MPC occurs in Lynch syndrome patients. CONCLUSION: Our findings demonstrate that both germline and somatic alterations are driving forces of carcinogenesis, which may resolve the carcinogenic theory of Lynch syndrome. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13045-017-0523-y) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-03 /pmc/articles/PMC5627420/ /pubmed/28974240 http://dx.doi.org/10.1186/s13045-017-0523-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Hu, Hai Li, Hong Jiao, Feng Han, Ting Zhuo, Meng Cui, Jiujie Li, Yixue Wang, Liwei Association of a novel point mutation in MSH2 gene with familial multiple primary cancers |
title | Association of a novel point mutation in MSH2 gene with familial multiple primary cancers |
title_full | Association of a novel point mutation in MSH2 gene with familial multiple primary cancers |
title_fullStr | Association of a novel point mutation in MSH2 gene with familial multiple primary cancers |
title_full_unstemmed | Association of a novel point mutation in MSH2 gene with familial multiple primary cancers |
title_short | Association of a novel point mutation in MSH2 gene with familial multiple primary cancers |
title_sort | association of a novel point mutation in msh2 gene with familial multiple primary cancers |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627420/ https://www.ncbi.nlm.nih.gov/pubmed/28974240 http://dx.doi.org/10.1186/s13045-017-0523-y |
work_keys_str_mv | AT huhai associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers AT lihong associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers AT jiaofeng associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers AT hanting associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers AT zhuomeng associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers AT cuijiujie associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers AT liyixue associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers AT wangliwei associationofanovelpointmutationinmsh2genewithfamilialmultipleprimarycancers |